666

LUKAS BIOMEDICAL INC

No trades
See on Supercharts
Market capitalization
‪1.24 B‬TWD
−2.00TWD
‪−47.35 M‬TWD
‪231.83 M‬TWD
Beta (1Y)
0.28
Employees (FY)
88
Change (1Y)
+20 +29.41%
Revenue / Employee (1Y)
‪85.82 K‬TWD
Net income / Employee (1Y)
‪−17.53 K‬TWD

About LUKAS BIOMEDICAL INC


CEO
Chao An Liu
Headquarters
Taipei
Founded
2013
ISIN
TW0006814007
FIGI
BBG00YPHS9K8
Lukas Biomedical, Inc. engages in the lease and sale of medical equipment. It operates through the Electronic Commerce and Medical Management segments. It also offers biotechnology beauty products and immune cell therapy. The company was founded on December 26, 2013 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6814 is 30.85 TWD — it has increased by 4.39% in the past 24 hours. Watch LUKAS BIOMEDICAL INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange LUKAS BIOMEDICAL INC stocks are traded under the ticker 6814.
6814 stock has risen by 4.75% compared to the previous week, the month change is a 4.75% rise, over the last year LUKAS BIOMEDICAL INC has showed a 6.78% increase.
6814 reached its all-time high on Mar 10, 2021 with the price of 75.65 TWD, and its all-time low was 22.40 TWD and was reached on Mar 15, 2024. View more price dynamics on 6814 chart.
See other stocks reaching their highest and lowest prices.
6814 stock is 5.10% volatile and has beta coefficient of 0.28. Track LUKAS BIOMEDICAL INC stock price on the chart and check out the list of the most volatile stocks — is LUKAS BIOMEDICAL INC there?
Today LUKAS BIOMEDICAL INC has the market capitalization of ‪1.24 B‬, it has increased by 0.34% over the last week.
Yes, you can track LUKAS BIOMEDICAL INC financials in yearly and quarterly reports right on TradingView.
6814 net income for the last half-year is ‪−40.66 M‬ TWD, while the previous report showed ‪−32.65 M‬ TWD of net income which accounts for −24.56% change. Track more LUKAS BIOMEDICAL INC financial stats to get the full picture.
No, 6814 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 88.00 employees. See our rating of the largest employees — is LUKAS BIOMEDICAL INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LUKAS BIOMEDICAL INC EBITDA is ‪−39.71 M‬ TWD, and current EBITDA margin is −5.15%. See more stats in LUKAS BIOMEDICAL INC financial statements.
Like other stocks, 6814 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUKAS BIOMEDICAL INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LUKAS BIOMEDICAL INC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LUKAS BIOMEDICAL INC stock shows the neutral signal. See more of LUKAS BIOMEDICAL INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.